Rational development of prophylactic HIV vaccines based on structural and regulatory proteins

Author： Mooij P.   Heeney J.L.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.3, 2001-11, pp. : 304-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospects and challenges for prophylactic and therapeutic HIV vaccines

By Klein M.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 616-619

Elsevier

Access to resources Recommend Favorite

Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application

By Betti M.   Voltan R.   Marchisio M.   Mantovani I.   Boarini C.   Nappi F.   Ensoli B.   Caputo A.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3408-3419

Elsevier

Access to resources Recommend Favorite

Vaccines in Argentina: a regulatory view

By Perez A.C.   Diez R.A.  

Vaccine, Vol. 21, Iss. 24, 2003-07 ,pp. : 3492-3496

Elsevier

Access to resources Recommend Favorite

The basis for HIV immunotherapeutic vaccines

By Peters B.S.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 688-705

Elsevier

Access to resources Recommend Favorite

HIV vaccines: the Uganda experience

By Mugyenyi P.N.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1905-1908

Elsevier

Access to resources Recommend Favorite